Antibody Development & Production（抗体的开发和制造）
CSS
学会概要
Mix-and-match sessions from these additional co-located conferences at no additional cost:
- Recombinant Protein & Complex Biologic Development & Production
- Analytical Technologies for Biotherapeutic Development
- Biobetters & Biosimilars: Technologies & Development Strategies
Arrive early so you can attend the first half of the week, Feb. 27-28 for these conferences:
学会详细介绍有助于各种规模的企业为开发或生产抗体、改善生产速度、品质和成本、以及在生物制程领域之技术面和科学面的新成果，是高水平的活动。能获得只有在此学会才能听到的个案研究，取得最新数据，藉由在策略性讨论论坛与领导业界的研究人员、技术人员及企业主管交换意见，能找到业界面临之最重要课题的解决办法。
"IBC continues to put together a well organized series of conferences that cover the key topics and areas of interest across the biotech industry. They provide an excellent forum to bring together leading scientists and companies to exchange ideas and create networking contacts." - William D. Taylor, Director, Business Development, Pfenex
学会的优点
- 能针对促进制程技术创新、集成、最适化的许多新要因进行检讨
- 能学习利用高滴定率制程的综合性方法
2012年的研习会介绍与下列主题有关的实绩方法、个案研究及未发表的数据等
- 制程开发的新波－藉由技术创新、集成、最适化来改善生物制程
- 引进利用高滴定率制程之成本效率高的新方法
- 部分改善上游制程和下游制程的接点
- 抗体设计对开发和生产业务的影响
- 细胞株的选定、开发、设计手法之进化
- 克服开发高浓度制剂和传递时的课题
- 改善制程开发中的产品品质
- 特性描述和相似性的新方法与策略
- 药物复合体的开发与生产
- 下一代的分子和新分子的开发与制造
在学会中能找到这些问题的解答。
Comparability Within A Single Product Differs from Biosimilarity Between Two Products
Anthony S. Lubiniecki, Sc.D.
Johnson & Johnson Pharmaceutical R&D, Inc.
Path to Approval for Antibody Drug Conjugates
Morris Rosenberg, D.Sc.
Seattle Genetics
Continuous Bioprocessing for Production of Biopharmaceuticals
Weichang Zhou, Ph.D.
Genzyme, a Sanofi Company
Application of Quality by Design Approach in Viral Clearance Studies: Be Prepared and Set a Realistic Expectation
Dayue Chen, Ph.D.
Eli Lilly and Company
Developing High Dose Monoclonal Antibody Formulations for SC Delivery
Steven J. Shire, Ph.D.
Genentech, Inc.
Special thanks to the Scientific Advisory Committee for their help in developing this program.
» View the list of committee members